GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Hvsen Biotechnology Co Ltd (SZSE:300871) » Definitions » Additional Paid-In Capital

Wuhan Hvsen Biotechnology Co (SZSE:300871) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Hvsen Biotechnology Co Additional Paid-In Capital?


Wuhan Hvsen Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0.0 Mil) to Dec. 2023 (¥874.0 Mil) but then stayed the same from Dec. 2023 (¥874.0 Mil) to Mar. 2024 (¥0.0 Mil).

Wuhan Hvsen Biotechnology Co's annual additional paid-in capital declined from Dec. 2021 (¥880.7 Mil) to Dec. 2022 (¥877.1 Mil) and declined from Dec. 2022 (¥877.1 Mil) to Dec. 2023 (¥874.0 Mil).


Wuhan Hvsen Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Wuhan Hvsen Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hvsen Biotechnology Co Additional Paid-In Capital Chart

Wuhan Hvsen Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 103.87 926.89 880.66 877.08 874.01

Wuhan Hvsen Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 874.01 - 874.01 -

Wuhan Hvsen Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Wuhan Hvsen Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Wuhan Hvsen Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hvsen Biotechnology Co (SZSE:300871) Business Description

Traded in Other Exchanges
N/A
Address
218 Zhangbai Road, Dongxihu District, Hubei Province, Wuhan, CHN, 430042
Wuhan Hvsen Biotechnology Co Ltd is engaged in research and development, production and sales of veterinary drugs (including chemical drug preparations, raw materials, and Chinese medicine preparations), feed and additives. It produces tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products.

Wuhan Hvsen Biotechnology Co (SZSE:300871) Headlines

No Headlines